VERA THERAPEUTICS Trademark
Trademark Overview
On Monday, September 29, 2025, a trademark application was filed for VERA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERA THERAPEUTICS trademark a serial number of 99418622. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, February 27, 2026. This trademark is owned by VERA THERAPEUTICS, INC.. The VERA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical research and development; medical and scientific research for development of pharmaceuticals and biologics for the treatment of diseases; provision of medical research and scientific research services and information in the field of pharmaceuticals, therapeutic preparations, and clinical trials; Medical and scientific research, namely, conducting clinical trials for others
Pharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases
General Information
| Serial Number | 99418622 |
| Word Mark | VERA THERAPEUTICS |
| Filing Date | Monday, September 29, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, February 27, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of stylized words "VERA THERAPEUTICS". |
| Goods and Services | Pharmaceutical research and development; medical and scientific research for development of pharmaceuticals and biologics for the treatment of diseases; provision of medical research and scientific research services and information in the field of pharmaceuticals, therapeutic preparations, and clinical trials; Medical and scientific research, namely, conducting clinical trials for others |
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 29, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 29, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | VERA THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005
US |
Trademark Events
| Event Date | Event Description |
| Monday, September 29, 2025 | NEW APPLICATION ENTERED |
| Monday, September 29, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 20, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, February 21, 2026 | ASSIGNED TO EXAMINER |
| Friday, February 27, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, February 27, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, February 27, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
